EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing RNA Delivery: Practical insights into NeoLNPTM transfection reagent

Xiaobao Chen, Yan Wu, Li Liu, Wei Wang

Methods · 2025

DOI: 10.1016/j.ymeth.2025.05.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods, 2025. Verfasst von Xiaobao Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Scindy Pharmaceutical, Co., Ltd., Suzhou Industrial Park, 215125 Suzhou, China. Electronic address: paulchen@scindypharm.com. Hauptthemen laut MEDLINE: Transfection, Nanoparticles, COVID-19, RNA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid advancement of RNA-based therapeutics, particularly in the wake of COVID-19 vaccine success, has prompted significant research into optimizing RNA delivery mechanisms. This study evaluates the NeoLNPTM RNA Transfection Kit developed by Scindy Pharmaceutical, which utilizes lipid nanoparticles (LNPs) for efficient RNA encapsulation and delivery. We systematically investigate various parameters affecting transfection efficiency, including RNA concentration, RNA/LNP volume ratios, mixing techniques, LNP stability, and culture media. Our results demonstrate that the optimal RNA concentration for transfection efficiency is around 40-60 ng/µL, with a 1:0.75-1:1 RNA-to-LNP ratio yielding the highest protein expression. Additionally, we find that gentle mixing techniques outperform harsher methods, and the stability of LNP-RNA complexes significantly influences transfection outcomes. This research provides practical guidelines for enhancing RNA transfection efficiency, paving the way for more effective RNA therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransfectionNanoparticlesCOVID-19RNAHumansLipidsSARS-CoV-2COVID-19 VaccinesLiposomes

Substanzen

LipidsLipid NanoparticlesRNACOVID-19 VaccinesLiposomes

Autor:innen und Institutionen

  • Scindy Pharmaceutical, Co., Ltd., Suzhou Industrial Park, 215125 Suzhou, China. Electronic address: paulchen@scindypharm.com.
  • Scindy Pharmaceutical, Co., Ltd., Suzhou Industrial Park, 215125 Suzhou, China.
  • Department of Chemistry, University of Bergen 5007 Bergen, Norway; Center for Pharmacy, University of Bergen 5020 Bergen, Norway. Electronic address: wei.wang@uib.no.

Zitieren

APA

Chen, X., Wu, Y., Liu, L., & Wang, W. (2025). Enhancing RNA Delivery: Practical insights into NeoLNPTM transfection reagent. Methods. https://doi.org/10.1016/j.ymeth.2025.05.007

Vancouver

Chen X, Wu Y, Liu L, Wang W. Enhancing RNA Delivery: Practical insights into NeoLNPTM transfection reagent. Methods. 2025. doi:10.1016/j.ymeth.2025.05.007

BibTeX
@article{Chen2025,
  author = {Chen, Xiaobao and Wu, Yan and Liu, Li and Wang, Wei},
  title = {Enhancing RNA Delivery: Practical insights into NeoLNPTM transfection reagent},
  journal = {Methods},
  year = {2025},
  doi = {10.1016/j.ymeth.2025.05.007}
}
Kostenlos starten →